Видео с ютуба Durvalumab

Phase II study of durvalumab + olaparib in patients with metastatic pancreatic cancer and DDR genes

DEBATE: neoadjuvant durvalumab and chemotherapy in localized BTC

TOURMALINE: durvalumab and gemcitabine-based chemotherapy in BTC

Clinical Experience With the AEGEAN Regimen

SIERRA: safety of durvalumab and tremelimumab in Asian patients with uHCC

Perioperative durvalumab plus FLOT improves outcomes in gastric cancer

MATTERHORN: Durvalumab perioperatorio en cáncer gástrico - Lo básico

Марсель Д'Альенде пережил рак легких | карбоплатин | пеметрексед | дурвалумаб | иммунотерапия

Durvalumab Plus BCG: A New Hope for High-Risk Bladder Cancer?

Evaluating durvalumab and chemotherapy for MIBC in the NIAGARA trial

Identifying and managing treatment-related toxicities in the NIAGARA trial

Одобрение FDA препарата Дурвалумаб с FLOT при резектабельной резекции желудка и ГЭП: MATTERHORN, ...

CALYPSO: final efficacy data and biomarker analysis in the ccRCC cohort

Durvalumab and BCG: A New Treatment Option for High-Risk Bladder Cancer

Дурвалумаб плюс БЦЖ: новая надежда в лечении немышечно-инвазивного рака мочевого пузыря высокого ...

Иммунотерапия МРЛ: прорывы в области дурвалумаба и проблемы биомаркеров

HIMALAYA: 5-year survival data of tremelimumab and durvalumab vs sorafenib in uHCC

Can Immunotherapy And Chemotherapy Improve Stomach Cancer Outcomes? - Stomach Cancer Support Network

Breakthrough Treatment: Durvalumab + FLOT Improves Survival Rates for Gastric Cancer Patients

Durvalumab + FLOT: New Standard of Care for Gastric/GEJ Adenocarcinoma? | MATTERHORN Trial Results